Proportion of the target population who received the final dose of in Central Asia

Central Asia: Proportion of the target population who received the final dose of was 59.0% in 2024. ◆ Volatile

Latest (2024)
59.0%
Change on year
up 9.3%
Rank
8th
of 35 groups
All-time high
59.0%
in 2024
All-time low
8.0%
in 2017
Years of data
8
2017–2024

Proportion of the target population who received the final dose of in Central Asia, 2017–2024

02040602017202020242017: 8 %2018: 8 %2019: 8 %2020: 50 %2021: 46 %2022: 51 %2023: 54 %2024: 59 %

Source: United Nations Statistics Division, SDG Global Database. Measured in %.

Analysis

Central Asia recorded 59.0% for proportion of the target population who received the final dose of in 2024. That is the highest value across all 8 years on record.

Compared with earlier readings it is up 9.3% on the previous year and up 637.5% over ten years.

That places Central Asia 8th out of 35 groups with data for 2024, putting it in the top quarter.

Proportion of the target population who received the final dose of in Central Asia, year by year

Annual values for Proportion of the target population who received the final dose of human papillomavirus (HPV) vaccine (%) in Central Asia, 2017 to 2024.
Year % Change
2017 8.0%
2018 8.0% +0.0%
2019 8.0% +0.0%
2020 50.0% +525.0%
2021 46.0% -8.0%
2022 51.0% +10.9%
2023 54.0% +5.9%
2024 59.0% +9.3%

Averages by decade

DecadeAverage LowestHighest Years
2010s 8.0% 8.0% 8.0% 3
2020s 52.0% 46.0% 59.0% 5

Countries ranked near Central Asia

  1. 5 United Republic of Tanzania 94.0% compare
  2. 6 Bhutan 92.0% compare
  3. 6 Mauritius 92.0% compare
  4. 6 Portugal 92.0% compare
  5. 9 Norway 91.0% compare
  6. 10 Spain 90.0% compare
  7. 11 Cyprus 89.0% compare
  8. 11 Ecuador 89.0% compare
  9. 11 Iceland 89.0% compare

See the full ranking of 142 places →

More infrastructure data for Central Asia

All data for Central Asia →

Frequently asked questions

What is proportion of the target population who received the final dose of in Central Asia?
Proportion of the target population who received the final dose of in Central Asia was 59.0% in 2024, according to United Nations Statistics Division, SDG Global Database.
What is the highest proportion of the target population who received the final dose of recorded in Central Asia?
The highest recorded value was 59.0% in 2024.
What is the lowest proportion of the target population who received the final dose of recorded in Central Asia?
The lowest recorded value was 8.0% in 2017.
How does Central Asia rank for proportion of the target population who received the final dose of?
Central Asia ranks 8th out of 35 groups with data for 2024.
Is proportion of the target population who received the final dose of rising or falling in Central Asia?
Over the last ten years it is up 637.5%. The long-run trend across the full record is volatile.
Where does this Central Asia data come from?
The figures come from United Nations Statistics Division, SDG Global Database, published as part of Proportion of the target population who received the final dose of human papillomavirus (HPV) vaccine (%). Statizoid updates them automatically from the source API.

Download this data

CSV · JSON — 8 observations, free to reuse under UN SDG Global Database (open, attribution requested).

Share, cite or embed this page

Cite this page

Proportion of the target population who received the final dose of in Central Asia. Statizoid, drawing on United Nations Statistics Division, SDG Global Database. Retrieved 07 September 2026, from https://infrastructure.statizoid.com/stat/proportion-of-the-target-population-who-received-the-final-dose-of-human-papillomavirus/central-asia/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under UN SDG Global Database (open, attribution requested); please keep the attribution.

<a href="https://infrastructure.statizoid.com/stat/proportion-of-the-target-population-who-received-the-final-dose-of-human-papillomavirus/central-asia/">Proportion of the target population who received the final dose of in Central Asia</a> — Statizoid

About this data

Indicator
Proportion of the target population who received the final dose of human papillomavirus (HPV) vaccine (%)
Unit
%
Source
United Nations Statistics Division, SDG Global Database
Licence
UN SDG Global Database (open, attribution requested)
Coverage
142 places, 1,601 data points, 2010–2024
Last refreshed